Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Private Equity Strategies

Movers & Shakers: Highland Capital Loses Boyce

Tuesday, September 02, 2014

Texas-based Highland Capital Management is losing its head of private equity after 10 years. Patrick Boyce will continue to serve on the board of some of Highland’s portfolio companies.

Highland Capital Management was founded in 1993 by Jim Dondero and Mark Okada, and primarily invests in high-yield credit. The firm has steadily expanded in the credit space and also into more pure play private equity investments.

Boyce will be relocating to Hawaii with his family, according to a statement from the firm.

Jim Dondero and John Honis will lead the firm’s private equity group going forward.

Apart from pure private equity, Highland has been able to capitalize on record CLO issuance this year. Total issuance topped $83 billion, beating last year’s $82.6 billion number. Other private equity firms including Apollo have also surpassed internal records with their CLO issuance. Apollo managed their largest CLO offerings to date in both the US and Europe this year.

Highland Capital founder Mark Okada, was featured in a two part interview on Opalesque TV where he discussed the invention and history of CLO’s as well as Highland’s investment approach.

“We don’t do anything just because we are getting fees, or that’s where money is flowing, or that’s a hot idea, the only thing that we do as a firm is where we like the arbitrage and we think we can add value with our platform and our arbitrage. We may see arbitrage that we think is cheap and it’s great and it’s underpriced, but we don’t have any people that know how to do that, that’s not what we are going to do,” Okada said in the interview.

Watch Part 1 here.

Watch Part 2 here.

 
This article was published in Opalesque's Private Equity Strategies our monthly research update on the global private equity landscape including all sectors and market caps.
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies


Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for